Occlutech International AB

Works in Cardiovascular · Genetic & rare · Neurology · Respiratory

Occlutech International AB is a clinical trial sponsor. It has 9 active clinical trials with 1,880 planned participants, in Cardiovascular, Genetic & rare, Neurology and Respiratory. Since 2021 it has completed 4 trials and stopped 1 early.

Trial track record · since 2021

9Active trials1,880 planned participants
4Completed0 with results posted
1Stopped early20% of finished trials

Pipeline · 9 active trials

StageTrialStatus

Questions about Occlutech International AB

See the rest of this profile

A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.

Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-10-16.

Approve Suite is not affiliated with Occlutech International AB.

See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.